Arkadios Wealth Advisors’s PHARMOS CORP NEW PARS Stock Holding History

Arkadios Wealth Advisors’s Portfolio PARS Stock Details PARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-400	Closed	-$12	–	1095
2020 Q2	$12	Hold	400	–	–	﹤0.01%	943
2020 Q1	$3	Buy	+400	New	+$3	﹤0.01%	1189

Arkadios Wealth Advisors's PARS Position: Q3 2020 in Review

Arkadios Wealth Advisors sold out of PHARMOS CORP NEW (PARS) in Q3 2020, closing a stake of 400 shares — an estimated $12 sold.

Arkadios Wealth Advisors first reported a position in PARS in Q1 2020 and held it in 2 quarters. The position peaked at $12 in Q2 2020. 0 funds tracked by Wall St. Rank hold PARS as of Q3 2020.

Arkadios Wealth Advisors reported no remaining PHARMOS CORP NEW position as of Q3 2020 after selling out during the quarter.
Arkadios Wealth Advisors sold 400 PHARMOS CORP NEW shares in Q3 2020, an estimated $12.
Arkadios Wealth Advisors first reported a position in PHARMOS CORP NEW in Q1 2020 and held it in 2 quarters.
Arkadios Wealth Advisors's PHARMOS CORP NEW position peaked at $12 in Q2 2020.
0 funds tracked by Wall St. Rank held PHARMOS CORP NEW as of Q3 2020.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2020, filed 10 Nov 2020.